Cases & Deals

Hope Pharmaceuticals develops global patent portfolio relating to highly purified forms of sodium nitrite and sodium thiosulfate

Clients Hope Pharmaceuticals

Jones Day represents Hope Pharmaceuticals in the establishment of a global patent portfolio related to highly purified forms of sodium nitrite and sodium thiosulfate relating to its FDA-approved cyanide antidote NITHIODOTE®.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.